Atomoxetine-d7hydrochloride (Tomoxetine-d7hydrochloride) is the deuterium-labeled version of Atomoxetine hydrochloride. This compound acts as a selective norepinephrine reuptake inhibitor, with Ki values for norepinephrine (NE), serotonin (5-HT), and dopamine (DA) transporters measured at 5 nM, 77 nM, and 1451 nM, respectively. Additionally, Atomoxetine hydrochloride serves as an effective sodium channel blocker (VGSCs) and is utilized in research concerning attention-deficit hyperactivity disorder (ADHD).
